Asset Details
Do you wish to reserve the book?
Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer
Do you wish to request the book?
Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer
2024
Overview
Background
Breast cancer treatment is multimodal, but not all patients benefit from each treatment, and many experience morbidities significantly impacting quality of life. There is increasing interest in tailoring breast cancer treatments to optimize oncological outcomes and reduce treatment burden, but it is vital that future trials focus on treatments that most impact patients. This study was designed to explore patient experiences of treatment to inform future research.
Methods
An online survey was co-developed with patient advocates to explore respondents’ experiences of breast cancer treatment. Questions included simple demographics, treatments received, and views regarding omitting treatments if that is deemed safe. The survey was circulated via social media and patient advocacy groups. Responses were summarized by using simple statistics; free text was analyzed thematically.
Results
Of the 235 participants completing the survey, 194 (82.6%) would choose to omit a specific treatment if safe to do so. The most commonly selected treatments were chemotherapy (
n
= 69, 35.6%) and endocrine therapy (
n
= 61, 31.4%) mainly due to side effects. Fewer respondents would choose to omit surgery (
n
= 40, 20.6%) or radiotherapy (
n
= 20, 10.3%). Several women commented that survival was their “absolute priority” and that high-quality evidence to support the safety of reducing treatment would be essential.
Conclusions
Patients with breast cancer are individuals who may wish to optimize different components of their treatment. A portfolio of studies co-designed with patients is needed to establish an evidence base for greater treatment personalization with studies focused on reducing avoidable chemotherapy and endocrine therapy a priority.
Publisher
Springer International Publishing,Springer Nature B.V
We currently cannot retrieve any items related to this title. Kindly check back at a later time.